Circulation, Vol 90, 108-113, Copyright © 1994 by American Heart Association
D Bonaduce, F Marciano, M Petretta, ML Migaux, G Morgano, V Bianchi, L Salemme, G Valva and M Condorelli
BACKGROUND: Heart period variability provides useful prognostic information
on autonomic cardiac control, and a strong association has been
demonstrated after myocardial infarction (MI) between cardiac mortality,
sudden death, and reduced total power, ultralow-frequency (ULF) power, and
very-low-frequency (VLF) power. Converting enzyme inhibitors are widely
used in MI patients, but their influence on heart period variability
remains to be defined. METHODS AND RESULTS: Time- and frequency-domain
measures of heart period variability were calculated from 24-hour Holter
monitoring in 40 patients with a first uncomplicated MI. After baseline
examination between 48 and 72 hours after symptom onset, patients were
randomly assigned to placebo or captopril administration, and on the third
day, 24-hour Holter monitoring was repeated. No changes in time and
frequency domain were detectable after placebo. After captopril, the SD of
all normal RR (NN) intervals (SDNN) increased from 90 +/- 29 to 105 +/- 30
milliseconds (P < .01); the SD of the average NN intervals for all
5-minute segments (SDANN index) and the mean of the SDs of all NN intervals
for all 5- minute segments (SDNN index) also increased from 74 +/- 24 to 90
+/- 26 milliseconds (P < .01) and from 45 +/- 17 to 49 +/- 15
milliseconds (P < .05), respectively. The root mean square successive
difference (r- MSSD) and the percent of differences between adjacent NN
intervals > 50 milliseconds (pNN50) remained unchanged. In regard to
frequency-domain measures, after captopril, total power (ln unit) increased
from 8.28 +/- 0.42 to 8.47 +/- 0.30 (P < .01); considering the frequency
bands, a significant increase was observed in ULF (P < .01), VLF (P <
.05), and low-frequency (LF) power (P < .05), whereas high-frequency
(HF) power remained unchanged. CONCLUSIONS: This study supports the
hypothesis that the renin-angiotensin system modulates the amplitude of ULF
and VLF power. Furthermore, it demonstrates that in MI patients, converting
enzyme inhibition favorably modifies measures of heart period variability
strongly associated with a poor prognosis.
ARTICLES
Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction
Institute of Internal Medicine, Cardiology, and Heart Surgery, University of Naples Federico II, Italy.
This article has been cited by other articles:
 |
|
 |
|
  T. Richardson, J. Baker, P.W. Thomas, C. Meckes, A. Rozkovec, and D. Kerr Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction QJM, June 16, 2009; (2009) hcp072v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Centurion The Open Artery Hypothesis: Beneficial Effects and Long-term Prognostic Importance of Patency of the Infarct-Related Coronary Artery Angiology, February 1, 2007; 58(1): 34 - 44. [Abstract] [PDF]
|
|
|
|
 |
|
 R. M. Carney, J. A. Blumenthal, K. E. Freedland, P. K. Stein, W. B. Howells, L. F. Berkman, L. L. Watkins, S. M. Czajkowski, J. Hayano, P. P. Domitrovich, et al. Low Heart Rate Variability and the Effect of Depression on Post-Myocardial Infarction Mortality Arch Intern Med, July 11, 2005; 165(13): 1486 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guzzetti, M. T. L. Rovere, G. D. Pinna, R. Maestri, E. Borroni, A. Porta, A. Mortara, and A. Malliani Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure Eur. Heart J., February 2, 2005; 26(4): 357 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P Frenneaux Autonomic changes in patients with heart failure and in post-myocardial infarction patients Heart, November 1, 2004; 90(11): 1248 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Roach, W. Wilson, D. Ritchie, and R. Sheldon Dissection of long-range heart rate variability: Controlled induction of prognostic measures by activity in the laboratory J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2271 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Petretta, L. Spinelli, F. Marciano, C. Apicella, M. L. E. Vicario, G. Testa, M. Volpe, and D. Bonaduce Effects of losartan treatment on cardiac autonomic control during volume loading in patients with DCM Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H86 - H92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Spinelli, M. Petretta, F. Marciano, G. Testa, M. A. E. Rao, M. Volpe, and D. Bonaduce Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1361 - H1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gustafsson, C. Torp-Pedersen, L. Kober, F. Gustafsson, P. Hildebrandt, and on behalf of the Trace Study Group Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction J. Am. Coll. Cardiol., July 1, 1999; 34(1): 83 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Domanski, D. V. Exner, C. B. Borkowf, N. L. Geller, Y. Rosenberg, and M. A. Pfeffer Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: A meta-analysis of randomized clinical trials J. Am. Coll. Cardiol., March 1, 1999; 33(3): 598 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Taylor, D. L. Carr, C. W. Myers, and D. L. Eckberg Mechanisms Underlying Very-Low-Frequency RR-Interval Oscillations in Humans Circulation, August 11, 1998; 98(6): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J C Vaile, J Fletcher, W A Littler, J H Coote, and J N Townend Angiotensin II modulates cardiovascular autonomic control in the absence of baroreflex loading Heart, August 1, 1998; 80(2): 127 - 133. [Abstract] [Full Text]
|
|
|
|
|
|
Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction : Systematic Overview of Individual Data From 100 000 Patients in Randomized Trials Circulation, June 9, 1998; 97(22): 2202 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K Yeragani, E. Sobolewski, J. Kay, V.C Jampala, and G. Igel Effect of age on long-term heart rate variability Cardiovasc Res, July 1, 1997; 35(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsuji, M. G. Larson, F. J. Venditti, E. S. Manders, J. C. Evans, C. L. Feldman, and D. Levy Impact of Reduced Heart Rate Variability on Risk for Cardiac Events: The Framingham Heart Study Circulation, December 1, 1996; 94(11): 2850 - 2855. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Petretta, D. Bonaduce, F. Marciano, V. Bianchi, G. Valva, C. Apicella, N. de Luca, and P. Gisonni Effect of 1 Year of Lisinopril Treatment on Cardiac Autonomic Control in Hypertensive Patients With Left Ventricular Hypertrophy Hypertension, March 1, 1996; 27(3): 330 - 338. [Abstract] [Full Text]
|
|